— Know what they know.
Not Investment Advice

XCUR NASDAQ

Exicure, Inc.
1W: -5.7% 1M: -10.8% 3M: -42.2% YTD: -79.4% 1Y: -72.0% 3Y: -67.6% 5Y: -99.4%
$1.15
-0.03 (-2.54%)
 
Weekly Expected Move ±10.5%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 26 · $7.3M mcap · 2M float · 22.46% daily turnover · Short 44% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$460K -192.0% ▼
Operating Income
-$10M +17.3% ▲
Net Income
-$5M +49.0% ▲
EPS (Diluted)
$-0.79 +50.3% ▲
EBITDA
-$10M -9.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue-$483K$29M$0$500K$0
YoY Growth-102.9%+6068.1%-100.0%+0.0%-100.0%
Cost of Revenue$0$2M$1M$0$460K
Gross Profit-$483K$27M-$1M$500K-$460K
Gross Margin100.0%93.6%—100.0%—
R&D Expenses$49M$20M$1M$0$3M
SG&A Expenses$13M$11M$13M$5M$7M
Operating Expenses$62M$29M$14M$13M$10M
Operating Income-$63M-$2M-$15M-$12M-$10M
Operating Margin12950.1%-6.4%—-2446.4%—
Interest Expense$2M$595K$0$18K$1K
Income Before Tax-$64M-$2M-$17M-$10M-$6M
Tax Expense$0$209K$0$8K-$634K
Net Income-$64M-$3M-$17M-$10M-$5M
Net Margin13271.6%-9.0%—-1940.2%—
EPS (Diluted)$-21.70$-0.56$-2.11$-1.59$-0.79
EBITDA-$61M$78K-$16M-$9M-$10M
Shares Outstanding3M5M8M6M6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms